Anadolu Insurance (ANSGR)
Stocks
Buy
Analyzes Anadolu Insurance's foreign currency position strength and financial resilience against currency increases.
FİNANS VE BORSA34d
* Does not constitute investment advice
Yükleniyor...
Yükleniyor...
How recommendation distribution changed over time
Covered by 5 analysts
Analysts are largely in agreement
Last evaluation 34+ days ago - stale data
One-directional consensus
Decreasing interest recently
Chronological view of analyst recommendations for this asset
Analyzes Anadolu Insurance's foreign currency position strength and financial resilience against currency increases.
FİNANS VE BORSAThe speaker examines the premium production data in the insurance sector and institutions' forecasts for high return potential.
BloombergHTAnadolu Insurance stock's extraordinary return potential between its average target price and current price is being examined. The attractive opportunities the stock offers to investors are being evaluated.
BloombergHTThe speaker interprets the impact of premium production growth on profitability and Q4 expectations.
BloombergHTThe speaker evaluates the company's financial performance expectations and sectoral position.
CNBC-eThe speaker evaluates the strong year-over-year growth rates in the company's premium production.
FİNANS VE BORSAIt is conveyed that it meets both cheapness and appreciation criteria as the only stock entering from the insurance sector in the financial companies list.
Kanal FinansThe speaker analyzes the growth trend in the health branch and premium production based on Marbaş Menkul's company notes.
BloombergHTAnalyzes Anadolu Insurance's foreign currency position strength and financial resilience against currency increases.
* Does not constitute investment advice
The speaker examines the premium production data in the insurance sector and institutions' forecasts for high return potential.
* Does not constitute investment advice
Anadolu Insurance stock's extraordinary return potential between its average target price and current price is being examined. The attractive opportunities the stock offers to investors are being evaluated.
* Does not constitute investment advice
The speaker interprets the impact of premium production growth on profitability and Q4 expectations.
* Does not constitute investment advice
The speaker evaluates the company's financial performance expectations and sectoral position.
* Does not constitute investment advice
The speaker evaluates the strong year-over-year growth rates in the company's premium production.
* Does not constitute investment advice
It is conveyed that it meets both cheapness and appreciation criteria as the only stock entering from the insurance sector in the financial companies list.
* Does not constitute investment advice
The speaker analyzes the growth trend in the health branch and premium production based on Marbaş Menkul's company notes.
* Does not constitute investment advice